Advertisement
Screener

MEDICINOVA, INC. (MNOV) Increase (Decrease) of Restricted Investments

2.8 / 5 stars · 68/120 Roast Me

MEDICINOVA, INC. Increase (Decrease) of Restricted Investments

MEDICINOVA, INC. (MNOV) reported Increase (Decrease) of Restricted Investments of -$5.98 thousand for the 156-month period ending 2013-09-30, per its 10-Q filed 2013-11-07.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseOfRestrictedInvestments · last filed 2013-11-07

  • MEDICINOVA, INC. increase (decrease) of restricted investments for the quarter ending 2013-09-30 was $0.00.
  • MEDICINOVA, INC. increase (decrease) of restricted investments for the quarter ending 2013-06-30 was $0.00.
  • MEDICINOVA, INC. increase (decrease) of restricted investments for the quarter ending 2013-03-31 was $0.00.
  • MEDICINOVA, INC. increase (decrease) of restricted investments for the quarter ending 2012-09-30 was $0.00.
  • MEDICINOVA, INC. increase (decrease) of restricted investments for fiscal 2011 was $17.00.
  • MEDICINOVA, INC. increase (decrease) of restricted investments for fiscal 2010 was -$6.00K.
Period endIncrease (Decrease) of Restricted Investments 3 monthIncrease (Decrease) of Restricted Investments 6 monthIncrease (Decrease) of Restricted Investments 9 monthIncrease (Decrease) of Restricted Investments 12 monthIncrease (Decrease) of Restricted Investments 129 monthIncrease (Decrease) of Restricted Investments 132 monthIncrease (Decrease) of Restricted Investments 135 monthIncrease (Decrease) of Restricted Investments 138 monthIncrease (Decrease) of Restricted Investments 141 monthIncrease (Decrease) of Restricted Investments 144 monthIncrease (Decrease) of Restricted Investments 147 monthIncrease (Decrease) of Restricted Investments 150 monthIncrease (Decrease) of Restricted Investments 153 monthIncrease (Decrease) of Restricted Investments 156 month
2013-09-30$0.00
derived: 10-Q 156 month − 10-Q 153 month · filed 2013-11-07
$0.00
derived: sum of 2 quarters · filed 2013-11-07
$0.00
derived: sum of 3 quarters · filed 2013-11-07
-$5.98K
10-Q · filed 2013-11-07
2013-06-30$0.00
derived: 10-Q 153 month − 10-Q 150 month · filed 2013-08-08
$0.00
derived: sum of 2 quarters · filed 2013-08-08
-$5.98K
10-Q · filed 2013-08-08
2013-03-31$0.00
derived: 10-Q 150 month − 10-K 147 month · filed 2013-05-08
-$5.98K
10-Q · filed 2013-05-08
2012-12-31-$5.98K
10-K · filed 2013-03-28
2012-09-30$0.00
derived: 10-Q 144 month − 10-Q 141 month · filed 2012-11-08
$0.00
derived: sum of 2 quarters · filed 2012-11-08
$0.00
derived: sum of 3 quarters · filed 2012-11-08
$0.00
derived: sum of 4 quarters · filed 2013-03-28
-$5.98K
10-Q · filed 2012-11-08
2012-06-30$0.00
derived: 10-Q 141 month − 10-Q 138 month · filed 2012-08-09
$0.00
derived: sum of 2 quarters · filed 2012-08-09
$0.00
derived: sum of 3 quarters · filed 2013-03-28
$0.00
derived: sum of 4 quarters · filed 2013-03-28
-$5.98K
10-Q · filed 2012-08-09
2012-03-31$0.00
derived: 10-Q 138 month − 10-K 135 month · filed 2012-05-10
$0.00
derived: sum of 2 quarters · filed 2013-03-28
$0.00
derived: sum of 3 quarters · filed 2013-03-28
-$5.98K
10-Q · filed 2012-05-10
2011-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28
$0.00
derived: sum of 2 quarters · filed 2013-03-28
$17.00
10-K · filed 2013-03-28
-$5.98K
10-K · filed 2012-03-29
2011-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08
$17.00
10-Q · filed 2012-11-08
-$5.98K
10-Q · filed 2011-11-14
2011-06-30$17.00
10-Q · filed 2012-08-09
-$5.98K
10-Q · filed 2011-08-15
2010-12-31-$232.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29
-$7.55K
derived: sum of 2 quarters · filed 2012-03-29
-$6.00K
10-K · filed 2012-03-29
2010-09-30$224.44K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14
$226.00K
10-Q · filed 2011-11-14
2010-06-30$1.55K
10-Q · filed 2011-08-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
NRX Pharmaceuticals, Inc. (NRXP)United States$0.131B-6.31
IMMUNIC, INC. (IMUX)United States$0.127B-1.88
Unicycive Therapeutics, Inc. (UNCY)United States$0.134B-3.70
TuHURA Biosciences, Inc./NV (HURA)United States$0.134B-4.88
INOVIO PHARMACEUTICALS, INC. (INO)United States$0.125B-1.35
Curanex Pharmaceuticals Inc (CURX)United States$0.138B
Aardvark Therapeutics, Inc. (AARD)United States$0.121B-1.80
CUMBERLAND PHARMACEUTICALS INC (CPIX)United States$0.121B-8.95
Coya Therapeutics, Inc. (COYA)United States$0.121B-6.35
Atrium Therapeutics, Inc. (RNA)United States$0.140B